Received Jun 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
she was was not sufficiently vaccinated against mumps and rubella.; she was was not sufficiently vaccinated against mumps and rubella.; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. Concomitant medications included leflunomide. On an unknown date, "in the 80's or 90's", the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) injection, administered for prophylaxis (dose, route of administration, anatomical location, lot # and expiration date were not reported). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (expiration date, and lot # were not reported). On an unspecified date in 2025 (reported as "recently"), the patient had measles, mumps and rubella titers drawn and it showed that she was not sufficiently vaccinated against mumps and rubella (the result of measles titer was not reported). The outcome of the events was not reported. Causality assessment was not provided. Lot# is being requested and will be submitted if received.
Leflunomide
Test Date: 2025; Test Name: mumps titer; Result Unstructured Data: the patient was not sufficiently vaccinated against mumps; Test Date: 2025; Test Name: rubella titer; Result Unstructured Data: the patient was not sufficiently vaccinated against rubella